Canada’s biotechnology ambitions need more than capital

Maximizing the opportunity will depend on ensuring employers can access the skilled workforce needed to commercialize, scale, and strengthen Canadian capacity.

Equally as important as money is access to the workforce needed to expand commercial production, enter global markets, and retain intellectual property in Canada, writes Rob Henderson. Pexels photograph by Ron Lach

Opinion

BY ROB HENDERSON

September 16, 2026

Canada is investing heavily in biotechnology. The federal government is supporting research, biomanufacturing infrastructure, and companies developing the next generation of health innovations. Canada’s inaugural Investment Summit from Sept. 14-15 reinforced the growing co...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES: